SPX4,071.70-4.87 -0.12%
DIA344.74+0.33 0.10%
IXIC11,461.50-20.95 -0.18%

BRIEF-Natco Pharma Says U.S. Appeals Court Rejected Alvogen's Appeal On Ibrutinib Tablets

Reuters · 11/15/2022 23:16
BRIEF-Natco Pharma Says U.S. Appeals Court Rejected Alvogen's Appeal On Ibrutinib Tablets

- Natco Pharma Ltd NATP.NS:

  • U.S. APPEALS COURT REJECTED MARKETING PARTNER ALVOGEN'S APPEAL ON IBRUTINIB TABLETS OF 140 MG, 280 MG, 420 MG AND 560 MG STRENGTH

  • NATCO AND ALVOGEN PINE BROOK LLC, USA, ARE ASSESSING THEIR OPTION ON WAY FORWARD

Source text for Eikon: ID:

Further company coverage: NATP.NS


((Reuters.Briefs@thomsonreuters.com;))